Pharma and MSF agree on competition for cheap vaccines, but differ on pricing
This article was originally published in Scrip
Executive Summary
Large pharmaceutical companies and Médecins sans Frontières may not often see eye-to-eye over access to medicines in poor countries. But it seems as if industry and the humanitarian body, a prominent critic, do agree that competition works in improving access to vaccines, even though they don't agree about the mechanisms of price setting.